Hemmo Yska

Mr. Hemmo Yska


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
HYHemmo Yska
Hemmo Yska
MEMarc Engelen
Marc Engelen
MBMarianna Bugiani
Marianna Bugiani
Although the pathology of X-linked adrenoleukodystrophy (ALD) is well described, it represents the end-stage of neurodegeneration. It is still unclear what cell types are initially involved and what their role is in the disease process. Revisiting the seminal post-mortem studies from the 1970s can generate new hypotheses on pathophysiology. This review describes (histo)pathological changes of the brain and spinal cord in ALD. It aims at integrating older works with current insights and at providing an overarching theory on the pathophysiology of ALD. The data point to an important role for axons and glia in the pathology of both the myelopathy and leukodystrophy of ALD. In-depth pathological analyses with new techniques could help further unravel the sequence of events behind the pathology of ALD.

25 May 2024 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
HYHemmo Yska
Hemmo Yska
BTBela R. Turk
Bela R. Turk
AFAli Fatemi
Ali Fatemi
JGJordan Goodman
Jordan Goodman
MVMarije Voermans
Marije Voermans
JKJennifer Keller
Jennifer Keller
Background: The most common manifestation of X‐linked adrenoleukodystrophy (ALD) is a slowly progressive myeloneuropathy, which leads to imbalance and gait disturbances. The variable progression of the disease complicates evaluation of its progression rate. Wearable sensors allow for easy and frequent balance and gait collection. This study reports baseline data from a longitudinal study on the quantitative assessment of balance and gait with wearable sensors and their clinical relevance.Methods: Data were collected from adult patients in two institutions. Postural body sway and gait parameters were measured using accelerometers. Disease severity was measured by the Expanded Disability Severity Scale (EDSS). Falling frequency and quality of life (QOL) were collected in men. The relationship between sway and gait variables and EDSS score, participants' use of a walking aid, and falling frequency was evaluated.Results: One hundred twenty individuals with ALD were included. Sway variables significantly differentiate participants' assistive device use. Sway and gait variables were correlated to the EDSS in both sexes. Both gait speed and sway were correlated with falling frequency in men from one institution. Select QOL subscores were correlated with the EDSS in males from one institution. Accelerometry generated comparable results across sites.Discussion: This study confirms the clinical correlation between spinal cord disease and imbalance and gait in ALD. For the first time, this study shows clinically meaningful relationships for sway and gait with use of an assistive device, falling frequency and QOL. Wearable accelerometers are a valid means to measure sway and gait in ALD. These measures are promising outcomes for clinical trial designs to assess myeloneuropathy in ALD and to monitor disease progression in individuals.

Verified
Journal Article
Open access
PDF file
HYHemmo Yska
Hemmo Yska
LHLidewij Henneman
Lidewij Henneman
RBRinse W. Barendsen
Rinse W. Barendsen
MEMarc Engelen
Marc Engelen
SKStephan Kemp
Stephan Kemp
Newborn screening (NBS) for X-linked adrenoleukodystrophy (ALD) can identify affected individuals before the onset of life-threatening manifestations. Some countries have decided to only screen boys (sex-specific screening). This study investigates the attitudes of individuals with ALD towards sex-specific NBS for ALD. A questionnaire was sent to all patients in the Dutch ALD cohort. Invitees were asked who they thought should be screened for ALD: only boys, both boys and girls or neither. The motives and background characteristics of respondents were compared between screening preferences. Out of 108 invitees, 66 participants (61%), 38 men and 28 women, participated in this study. The majority (n = 53, 80%) favored screening both newborn boys and girls for ALD, while 20% preferred boys only. None of the respondents felt that newborns should not be screened for ALD. There were no differences in the background characteristics of the respondents between screening preferences. Our study revealed a diverse range of motivations underlying respondents’ screening preferences. This study is one of the first to investigate the attitudes of patients towards sex-specific screening for ALD. The outcomes of this study can offer insights to stakeholders engaged in the implementation of NBS programs. ALD patients are important stakeholders who can provide valuable input in this process.

1 September 2025 in Brain Communications
Verified
Journal Article
Open access
HYHemmo Yska
Hemmo Yska
MSMenno D Stellingwerff
Menno D Stellingwerff
SRStefan D Roosendaal
Stefan D Roosendaal
MVMarije M C Voermans
Marije M C Voermans
MKMarjo S van der Knaap
Marjo S van der Knaap
MEMarc Engelen
Marc Engelen
The pathophysiology of X-linked adrenoleukodystrophy (ALD) is not well-understood. New quantitative MRI (qMRI) sequences, such as myelin-water imaging (MWI) and multi-shell diffusion-weighted imaging (DWI), are non-invasive techniques that can investigate microstructural abnormalities in the brain. Using these techniques, this study investigated abnormal white matter of cerebral ALD (cALD) lesions and normal-appearing white matter (NAWM) in ALD and in controls. Adult participants were scanned on 3T MRI scanners. Fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD) were measured with diffusion tensor imaging (DTI). The neurite density index (NDI) was established using neurite orientation dispersion and density imaging (NODDI). Myelin water fractions (MWF) were evaluated with multi-compartment relaxometry diffusion-informed MWI (MCR-DIMWI) and multi-echo T2-relaxation imaging with compressed sensing (METRICS). Measures were evaluated in 10 regions of interest (ROIs) in participants with and without cALD, and in controls. A total of 81 ALD participants (69% males, of whom 17 had cALD), and 21 controls were included. FA, NDI, MWFMETRICS and MWFMCR-DIMWI were significantly lower in lesions in the corpus callosum of cALD participants than in controls. FA, NDI and MWFMETRICS also significantly differentiated the NAWM of male, but not female, ALD participants from controls. FA and NDI had the largest effect sizes for males. In the NAWM, RD was increased, whereas AD was mostly unaffected. In a few NAWM regions, qMRI measures also differed between males with and without cALD. The NAWM of males with ALD contains microstructural abnormalities. Myelin and myelinated axons are impacted by ALD pathophysiology. These techniques have potential for clinical applications.

7 January 2025 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
HYHemmo Yska
Hemmo Yska
MVMarije Voermans
Marije Voermans
EKEda Kabak
Eda Kabak
MEMarc Engelen
Marc Engelen
This study presents the longest systematic prospective follow‐up of spinal cord disease in adult male ALD patients to date. Standardized yearly quantitative data collection included scoring of the EDSS, SSPROM, 6‐min walking test (6MWT), urological and quality of life questionnaires and vibration sense of the hallux. Progression rates were compared between patients with mild (EDSS ≤ 2.5) and moderate to severe (EDSS > 2.5) disability over a period of 7 years. Data from 79 patients was included. EDSS, SSPROM and 6MWT showed significant disease progression over time. The general progression pattern was linear. Stratified by disease severity, the increase in EDSS was 0.1 points per year in the low EDSS group and 0.2 points per year in the higher EDSS group. SSPROM decreased by −0.7 points per year in the low EDSS group and by −1.9 points per year in the higher EDSS group. 6MWT decreased by −9.3 m/year in the low EDSS group and by −18.2 m/year in the higher EDSS group. The rate of progression in patients with relatively severe disability was higher than in patients with mild disability. Clinical trials will therefore observe effects more rapidly in patients with more advanced disease.

10 March 2026 in Neurology
Verified
Journal Article
Open access
PDF file
HYHemmo Yska
Hemmo Yska
MGMarianne Golse
Marianne Golse
DGDamien Galanaud
Damien Galanaud
HAHernan M. Amartino
Hernan M. Amartino
CBCaroline Bergner
Caroline Bergner
FMFanny MOCHEL
Fanny MOCHEL
Background and ObjectivesCerebral adrenoleukodystrophy (CALD) is a common manifestation of adrenoleukodystrophy (ALD) in men. Early detection of CALD lesions through MRI screening is critical to al...